World Diabetes Day: Understanding the Global Shortage of Semaglutide

Every year on November 14, the medical community marks World Diabetes Day, a reminder of the global effort to prevent, detect, and manage one of the world’s most widespread chronic diseases. This year, the date arrives amid growing concern about the shortage of key diabetes medications such as Ozempic, Rybelsus, and Wegovy—all based on a compound called semaglutide.

For many patients, these medications are not optional. They are essential for maintaining stable blood sugar levels and preventing complications such as neuropathy, kidney failure, and cardiovascular disease. Yet, as demand increases worldwide, diabetic patients are finding it harder to access their treatments.

Why is this happening, and what can patients do about it?

What Is Semaglutide and Why It Matters

Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which mimic a hormone naturally released by the intestines after eating. This mechanism helps stimulate insulin production while reducing excess glucose in the bloodstream.

For people with type 2 diabetes, semaglutide helps to:

• Improve glycemic control

• Reduce appetite and support weight management

• Lower cardiovascular risks

• Prevent long-term complications

Because of these benefits, semaglutide has become one of the most prescribed medications for diabetes worldwide. Unfortunately, its success has also contributed to its scarcity.

The Weight Loss Boom and Its Side Effects

Originally designed for diabetes treatment, semaglutide also promotes significant weight loss by reducing appetite. This discovery led to the creation of Wegovy, a formulation approved specifically for obesity management.

However, the popularity of semaglutide as a "weight loss solution" among non-diabetic individuals has caused a surge in demand that far exceeds pharmaceutical supply. Social media promotion and celebrity endorsements have amplified the trend, leading many people to seek these medications off-label, without medical supervision.

The result has been a global shortage, leaving many diabetic patients unable to find the medication they rely on for daily health and safety.

The Risks of Using Semaglutide Without Medical Supervision

Although semaglutide is highly effective, it must be prescribed and monitored by a healthcare professional. Self-medication or obtaining it without a proper diagnosis can lead to serious side effects, such as:

• Pancreatitis or gallbladder inflammation

• Nausea, vomiting, and dehydration

• Visual disturbances and worsening diabetic retinopathy

• Nutritional deficiencies or sudden weight fluctuations

For individuals without diabetes, the risks often outweigh the benefits. The medication alters how the body regulates insulin and hunger, and misuse can trigger dangerous metabolic imbalances.

Ethical and Medical Implications

The current shortage raises broader ethical questions. Should medications developed for chronic diseases be accessible for cosmetic purposes while patients with medical needs face shortages?

Pharmaceutical companies and health authorities are now working to balance production and distribution. However, the responsibility also lies with medical professionals to prescribe these drugs appropriately and with patients to seek evidence-based guidance instead of online shortcuts.

What Diabetic Patients Can Do

If you are struggling to find your semaglutide prescription, it is important to:

1. Contact your physician early to explore alternative treatment options or dosage adjustments.

2. Avoid purchasing from unverified sources or online platforms offering unregulated versions.

3. Monitor your glucose regularly and report any unusual readings to your doctor.

4. Discuss temporary alternatives, such as other GLP-1 agonists or adjusted insulin therapy.

5. Stay informed through official health organizations regarding supply updates.

A proactive medical plan helps minimize disruption and maintains your stability even during shortages.

The Bigger Picture: Prevention and Awareness

World Diabetes Day is not just about raising awareness of the disease. It is also about promoting responsible healthcare choices, supporting access to essential medication, and encouraging lifestyle changes that prevent diabetes-related complications.

Balanced nutrition, regular exercise, and routine check-ups remain the foundation of effective diabetes management. For travelers or expatriates in Barcelona, having a trusted English-speaking doctor can ensure continuity of care and timely advice in case of treatment interruptions.

About the author

Dr. Stefan Botnar, MD – English Speaking Doctor in Barcelona for Tourists Dr. Stefan Botnar is a board-certified English-speaking doctor in Barcelona with over 15 years of experience in internal medicine and public health. He provides fast, out-of-pocket consultations for international patients, specializing in preventive care, substance metabolism, travel-related issues, and especially STD/ETS testing and treatment. His clinic, located at Carrer de la Marina, 16–18, Torre Mapfre, Barcelona, offers in-person and telemedicine appointments, immunizations, nutritional advice, and minor emergency care (fever, gastroenteritis, allergic reactions). Patients pay directly, no insurers required. Dr. Botnar speaks English, Spanish, Russian, Romanian, and German, ensuring clear communication with a diverse tourist clientele. He delivers evidence-based diagnoses and tailored treatment plans, helping visitors prevent common ailments (heatstroke, food poisoning) and offering comprehensive follow-up until they return home. As a specialist in internal medicine, Dr. Botnar also focuses on the mind-body connection, supporting patients in navigating seasonal transitions and maintaining balance while traveling.

Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider if you experience persistent or worsening symptoms.